Literature DB >> 2746023

Cerebral interferon entry in mice after osmotic alteration of blood-brain barrier.

M Wiranowska1, T C Wilson, K Thompson, L D Prockop.   

Abstract

Systemically administered interferon (IFN) is not readily detected in the central nervous system (CNS) due to the presence of the blood-brain barrier (BBB). A method of osmotic BBB alteration in a mouse model was established in this laboratory. IFN's entry into the normal and osmotically altered brain after its intracarotid injection was investigated. Significant IFN levels (100-1,000 units) in the brain can be achieved by this method. The highest IFN activity was found in the brain hemisphere ipsilateral to the injection site within 20 min to 1 h after injection. IFN activity in the brain was detectable up to 4 h. Animals injected in this manner with murine IFN-alpha/beta (MuIFN-alpha/beta) and observed for a 6-month time interval showed no signs of neurological dysfunctions and resumed their normal activities. The therapeutic value of this method will be tested in a murine model of malignant glioma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2746023     DOI: 10.1089/jir.1989.9.353

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  5 in total

1.  Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.

Authors:  M Makino; Y Kitano; C Komiyama; M Hirohashi; K Takasuna
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  Effects of chronic administration of interferon alpha A/D on serotonergic receptors in rat brain.

Authors:  S Abe; T Hori; T Suzuki; A Baba; H Shiraishi; T Yamamoto
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

3.  Combination therapy with rituximab and temozolomide for recurrent and refractory primary central nervous system lymphoma.

Authors:  Mineko Murakami; Takamitsu Fujimaki; Shuichiro Asano; Hiroshi Nakaguchi; Shoko M Yamada; Katsumi Hoya; Kazuto Yamazaki; Yasuo Ishida; Akira Matsuno
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

4.  Evaluation of blood-brain barrier permeability and the effect of interferon in mouse glioma model.

Authors:  M Wiranowska; A A Gonzalvo; S Saporta; O R Gonzalez; L D Prockop
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

5.  Safety and efficacy of Qurse-e-istisqua in chronic hepatitis C infection: an exploratory study.

Authors:  Harmeet Singh Rehan; Deepti Chopra; Madhur Yadav; Neeta Wardhan; Seema Manak; K M Siddiqui; Mohd Aslam
Journal:  Indian J Pharmacol       Date:  2015 Jan-Feb       Impact factor: 1.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.